fingolimod hydrochloride has been researched along with lysophosphatidic acid in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (lysophosphatidic acid) | Trials (lysophosphatidic acid) | Recent Studies (post-2010) (lysophosphatidic acid) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 1,950 | 17 | 1,116 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | lysophosphatidic acid (IC50) |
|---|---|---|---|
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.4998 | |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | 0.4709 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, J; Arima, N; Kano, K; Kitamura, H; Makide, K | 1 |
| Peyruchaud, O | 1 |
2 review(s) available for fingolimod hydrochloride and lysophosphatidic acid
| Article | Year |
|---|---|
[Lysophospholipid mediators].
Topics: Animals; Cell Physiological Phenomena; Drug Design; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation; Insulin; Insulin Secretion; Lysophospholipids; Neurotransmitter Agents; Propylene Glycols; Receptors, G-Protein-Coupled; Sphingosine | 2009 |
Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
Topics: Fingolimod Hydrochloride; Humans; Lysophospholipids; Neoplasms; Propylene Glycols; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Sphingosine | 2009 |